Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1982;50:856-864

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Litten, R. Z.
Right arrow Articles by Alpert, N. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Litten, R. Z., 3d
Right arrow Articles by Alpert, N. R.

Circulation Research, Vol 50, 856-864, Copyright © 1982 by American Heart Association


ARTICLES

Altered myosin isozyme patterns from pressure-overloaded and thyrotoxic hypertrophied rabbit hearts

RZ Litten 3d, BJ Martin, RB Low and NR Alpert

Cardiac hypertrophy, induced by pressure overload, leads to a depression in the rate of force development, velocity of shortening, tension-dependent heat generation, and myosin ATPase activity, whereas cardiac hypertrophy, induced by thyroxine administration, leads to an increase in these parameters. These changes have been attributed, in part, to structural changes in myosin. In this study, we have investigated changes in the relative content of myosin isozymes and differences in primary structure of the isozymes in pressure-overloaded and thyrotoxic cardiac hypertrophy in the rabbit. Three myosin isozymic forms (V1 = fastest, V2 = intermediate, V3 = slowest mobility) were observed in pyrophosphate polyacrylamide gels from normal hearts with the V3 component being the predominant species. In the pressure- overloaded model, the V1 and V2 components disappeared or were present in reduced amounts leaving the V3 more predominant. The most striking difference was the isozymic profile produced in thyrotoxic hearts where the V1 became the predominant component and V2 and V3 the minor components. alpha-Chymotryptic digestion of myosin heavy chains produced characteristic, reproducible peptide patterns for each of the animal models, as did fluorographic analyses of alpha-chymotryptic digests of 14C-iodoacetamide (IAA)-labeled SH1 peptides of myosin. Our results suggest that altered proportions of myosin isozymes may be responsible for altered cardiac performance.


This article has been cited by other articles:


Home page
Circ Heart FailHome page
T. Suzuki, B. M. Palmer, J. James, Y. Wang, Z. Chen, P. VanBuren, D. W. Maughan, J. Robbins, and M. M. LeWinter
Effects of Cardiac Myosin Isoform Variation on Myofilament Function and Crossbridge Kinetics in Transgenic Rabbits
Circ Heart Fail, July 1, 2009; 2(4): 334 - 341.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. A. Hypolite, S. Chang, E. LaBelle, G. J. Babu, M. Periasamy, A. J. Wein, and S. Chacko
Deletion of SM-B, the high ATPase isoform of myosin, upregulates the PKC-mediated signal transduction pathway in murine urinary bladder smooth muscle
Am J Physiol Renal Physiol, March 1, 2009; 296(3): F658 - F665.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger
Designing Heart Performance by Gene Transfer
Physiol Rev, October 1, 2008; 88(4): 1567 - 1651.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
F. S. Korte and K. S. McDonald
Sarcomere length dependence of rat skinned cardiac myocyte mechanical properties: dependence on myosin heavy chain
J. Physiol., June 1, 2007; 581(2): 725 - 739.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Friehs, R. Barillas, N. V. Vasilyev, N. Roy, F. X. McGowan, and P. J. del Nido
Vascular Endothelial Growth Factor Prevents Apoptosis and Preserves Contractile Function in Hypertrophied Infant Heart
Circulation, July 4, 2006; 114(1_suppl): I-290 - I-295.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. S. Korte, T. J. Herron, M. J. Rovetto, and K. S. McDonald
Power output is linearly related to MyHC content in rat skinned myocytes and isolated working hearts
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H801 - H812.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Fujii, T. Nozawa, A. Igawa, B.-i. Kato, N. Igarashi, M. Nonomura, H. Asanoi, S. Tazawa, M. Inoue, and H. Inoue
Saturated glucose uptake capacity and impaired fatty acid oxidation in hypertensive hearts before development of heart failure
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H760 - H766.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
I. Friehs, A. M. Moran, C. Stamm, Y.-H. Choi, D. B. Cowan, F. X. McGowan, and P. J. del Nido
Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury
Ann. Thorac. Surg., June 1, 2004; 77(6): 2004 - 2010.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Golomb, X. Ma, S. S. Jana, Y. A. Preston, S. Kawamoto, N. G. Shoham, E. Goldin, M. A. Conti, J. R. Sellers, and R. S. Adelstein
Identification and Characterization of Nonmuscle Myosin II-C, a New Member of the Myosin II Family
J. Biol. Chem., January 23, 2004; 279(4): 2800 - 2808.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Minakawa, K. Takeuchi, K. Ito, T. Tsushima, K. Fukui, S. Takaya, and I. Fukuda
Restoration of sarcoplasmic reticulum protein level by thyroid hormone contributes to partial improvement of myocardial function, but not to glucose metabolism in an early failing heart
Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 493 - 501.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. W. Dorn II, J. Robbins, and P. H. Sugden
Phenotyping Hypertrophy: Eschew Obfuscation
Circ. Res., June 13, 2003; 92(11): 1171 - 1175.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Krenz, A. Sanbe, F. Bouyer-Dalloz, J. Gulick, R. Klevitsky, T. E. Hewett, H. E. Osinska, J. N. Lorenz, C. Brosseau, A. Federico, et al.
Analysis of Myosin Heavy Chain Functionality in the Heart
J. Biol. Chem., May 2, 2003; 278(19): 17466 - 17474.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. Miller, J. Maycock, E. White, M. Peckham, and S. Calaghan
Heterologous expression of wild-type and mutant {beta}-cardiac myosin changes the contractile kinetics of cultured mouse myotubes
J. Physiol., April 1, 2003; 548(1): 167 - 174.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. R. Alpert, C. Brosseau, A. Federico, M. Krenz, J. Robbins, and D. M. Warshaw
Molecular mechanics of mouse cardiac myosin isoforms
Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1446 - H1454.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. J. Herron and K. S. McDonald
Small Amounts of {alpha}-Myosin Heavy Chain Isoform Expression Significantly Increase Power Output of Rat Cardiac Myocyte Fragments
Circ. Res., June 14, 2002; 90(11): 1150 - 1152.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
I. Friehs, C. Stamm, H. Cao-Danh, F. X. McGowan Jr, and P. J. del Nido
Insulin-like growth factor-1 improves postischemic recovery in hypertrophied hearts
Ann. Thorac. Surg., November 1, 2001; 72(5): 1650 - 1656.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. N Peterson, R. Nassar, P. A W Anderson, and N. R Alpert
Altered cross-bridge characteristics following haemodynamic overload in rabbit hearts expressing V3 myosin
J. Physiol., October 15, 2001; 536(2): 569 - 582.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. J. Herron, F. S. Korte, and K. S. McDonald
Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression
Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1217 - H1222.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Friehs, A. M. Moran, C. Stamm, S. D. Colan, K. Takeuchi, H. Cao-Danh, C. M. Rader, F. X. McGowan, and P. J. del Nido
Impaired Glucose Transporter Activity in Pressure-Overload Hypertrophy Is an Early Indicator of Progression to Failure
Circulation, November 9, 1999; 100 (2009): II-187 - II-193.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. A Palmiter, M. J Tyska, D. E Dupuis, N. R Alpert, and D. M Warshaw
Kinetic differences at the single molecule level account for the functional diversity of rabbit cardiac myosin isoforms
J. Physiol., September 15, 1999; 519(3): 669 - 678.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. D. Blank, J. A. Lahorra, R. S. McDonald, A. G. Denenberg, J. S. Titus, D. F. Torchiana, W. M. Daggett, and G. A. Geffin
Superior Recovery of Hypertrophied Rat Myocardium After Cardioplegic Arrest
Ann. Thorac. Surg., February 1, 1998; 65(2): 390 - 396.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. VanBuren, D. E. Harris, N. R. Alpert, and D. M. Warshaw
Cardiac V1 And V3 Myosins Differ in Their Hydrolytic and Mechanical Activities In Vitro
Circ. Res., August 1, 1995; 77(2): 439 - 444.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
G. A. Bergeron, R. Goldsmith, and N. B. Schiller
Myocardial Infarction, Severe Reversible Ischemia, and Shock Following Excess Thyroid Administration in a Woman With Normal Coronary Arteries
Arch Intern Med, June 1, 1988; 148(6): 1450 - 1453.
[Abstract] [PDF]